UNSPSC 51281710: Amoxicillin anhydrous

This classification denotes a penicillin antibiotic with the molecular formula C16H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9EM05410Q9, chemically known as amoxicillin (anhydrous), but more generally known as amoxicillin anhydrous, which bears US NIH Compound Identifier 33613. European Medicines Agency schedules amoxicillin anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05481MIG. Most nations, for tariff purposes, schedule amoxicillin anhydrous under HS 29411010.

Amoxicillin anhydrous bears US NLM identifiers UMLS ID C2828282 and NCI Concept Code C87367. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3CCC(CC3)O)N)C(=O)O)C.

UNSPSC 51281710 Amoxicillin anhydrous, a Commodity code, shows a fundamental mismatch between its nominal scope and recent state and local procurement activity. The code specifically denotes a single antibiotic product, yet the recent opportunities tagged to it span naloxone dispensing systems, direct-to-manufacturer pharmaceutical programs, emergency medical supplies, and multi-source generic pharmaceuticals and OTC products — none of which are amoxicillin anhydrous. The state and local procurement records do not support active solicitation of amoxicillin anhydrous specifically; the opportunities instead reflect broader pharmaceutical procurement, emergency medical supply acquisition, and pharmacy benefit program redesign across public health departments, fire departments, and cooperative purchasing alliances.

The issuing bodies in the recent record include Seminole County's public health function, the Texas Health and Human Services Commission, the City of Tampa's fire department, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) with Oregon participation. Geographic activity appears in Florida, Texas, Minnesota, and Oregon, though the Texas RFI and MMCAP solicitation are exploratory information-gathering phases rather than formal awards. Concrete examples include Seminole County's IFB 60459723LAS (closed July 26, 2023) for naloxone and drug deactivation systems; the City of Tampa's IFB 26P00145 (closed March 13, 2026) for medical and first aid supplies to the Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a small-business enterprise sheltered-market set-aside; and MMCAP's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. This code shows little relevant recent activity; the opportunities appear to be data-quality issues or over-tagging rather than actual amoxicillin procurement.